Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIITerminatedJun 12, 2013Voltaren GelLabeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.Novartis Consumer Health · D-577-2013Class IIITerminatedJun 12, 2013Lamisil AT CreamLabeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.Novartis Consumer Health · D-576-2013Class IIITerminatedJun 12, 2013Novartis Lamisil AT Cream for Jock ItchLabeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.Novartis Consumer Health · D-575-2013Class IIITerminatedJun 12, 2013Target Up & UpLabeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..Novartis Consumer Health · D-574-2013Class IIITerminatedJun 12, 2013Novartis Lamisil AT CreamLabeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.Novartis Consumer Health · D-573-2013Class IITerminatedJun 12, 2013Tri-Mix Injections in 5 mL and 10 mL vialsLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-572-2013Class IITerminatedJun 12, 2013MIC (MethionineLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-571-2013Class IITerminatedJun 12, 2013Praziquantel 56.8 mgLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-570-2013Class IITerminatedJun 12, 2013Carnosine 5% Opth dropLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-569-2013Class IITerminatedJun 12, 2013Morphine Sulfate 25 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-568-2013Class IITerminatedJun 12, 2013Testosterone Cypionate 200 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-567-2013Class IITerminatedJun 12, 2013MIC (MethionineLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-566-2013Class IITerminatedJun 12, 2013Phosphatidyl Choline 10%Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-565-2013Class IITerminatedJun 12, 2013B-Complex 100 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-564-2013Class IITerminatedJun 12, 2013Ascorbic Acid 500 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-563-2013Class IITerminatedJun 12, 2013Procaine 1% InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-562-2013Class IITerminatedJun 12, 2013Methylcobalamin 1Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-561-2013Class IITerminatedJun 12, 2013Mitomycin 0.3 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-560-2013Class IITerminatedJun 12, 2013Lipoic Acid 25 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-559-2013Class IITerminatedJun 12, 2013Glutathione 200 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-558-2013Class IITerminatedJun 12, 2013Sodium EDTA 150 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-557-2013Class IITerminatedJun 12, 2013Hydroxyprogesterone 250 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-556-2013Class IITerminatedJun 12, 2013Dexamethasone 10 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-555-2013Class IITerminatedJun 12, 2013Dexpanthenol 200 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-554-2013Class IITerminatedJun 12, 2013Betamethasone 6 mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-553-2013Class IITerminatedJun 12, 2013Baclofen/Bupivacaine 2Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesThe Compounding Shop, Inc. · D-552-2013Class IITerminatedJun 12, 2013Baclofen 1Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.The Compounding Shop, Inc. · D-551-2013Class IITerminatedJun 12, 2013Baclofen 500 mcg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.The Compounding Shop, Inc. · D-550-2013Class IITerminatedJun 12, 2013Avastin 1.25 mg/0.05 mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.The Compounding Shop, Inc. · D-549-2013Class IITerminatedJun 12, 2013Methotrexate 25mg/mL InjectableLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.The Compounding Shop, Inc. · D-548-2013Class IITerminatedJun 12, 2013Metronidazole TabletsFailed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.Physicians Total Care, Inc. · D-547-2013Class IITerminatedJun 12, 2013ZoDen PDCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-546-2013Class IITerminatedJun 12, 2013ZoDen DM DropsCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-545-2013Class IITerminatedJun 12, 2013Z-Dex SyrupCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-544-2013Class IITerminatedJun 12, 2013Z-Dex Pediatric DropsCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-543-2013Class IITerminatedJun 12, 2013Trigofen DM DropsCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-542-2013Class IITerminatedJun 12, 2013Trigofen DropsCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-541-2013Class IITerminatedJun 12, 2013Tri-Dex PECGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-540-2013Class IITerminatedJun 12, 2013TL-Hist PD DropsCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-539-2013Class IITerminatedJun 12, 2013TL Hist DMCGMP Deviations: Products are underdosed or have an incorrect dosage regime.TG United, Inc. · D-538-2013

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.